Stock Price Forecast

Feb. 1, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Sun BioPharma Inc chart...

About the Company

We do not have any company description for Sun BioPharma Inc at the moment.

Please visit http://www.sunbiopharma.com/ for more information about the company.

CEO

Michael Cullen

Exchange

NASDAQ CAPITAL MARKET

Website

http://www.sunbiopharma.com/

$10M

Total Revenue

100K

Employees

$655M

Market Capitalization

277.50

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SNBP News

Sun BioPharma, Inc. News

1mon ago, source: TheStreet.com

Huang's Nvidia, one of the top performing stocks over the last year, will issue what's expected to be a whopper of an earnings report on Wednesday. The standard deduction reduces the amount of ...

IPO Preview: Sun BioPharma Starts $12 Million IPO Process

3y ago, source: TheStreet.com

The firm is a clinical stage biopharma advancing a small molecule treatment candidate for pancreatic cancer and other solid tumors. Sun BioPharma (SNBP) aims to raise $12 million in an IPO of its ...

Sunshine Biopharma Inc SBFM

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Panbela Therapeutics Inc (PBLA)

22d ago, source: Investing

Panbela Therapeutics, Inc. (PBLA) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

Navigating 4 Analyst Ratings For Sutro Biopharma

2d ago, source: Business Insider

Discovering Sutro Biopharma: A Closer Look Sutro Biopharma Inc is clinical-stage drug discovery, development, and ...

Vor Biopharma Inc Ordinary Shares VOR

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

FWBI First Wave BioPharma, Inc.

13d ago, source: Seeking Alpha

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with ...

First Wave BioPharma (FWBI) Upgraded to Buy: What Does It Mean for the Stock?

1d ago, source: Zacks.com on MSN

Investors might want to bet on First Wave BioPharma, Inc. (FWBI), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

KRBP Kiromic BioPharma, Inc.

7d ago, source: Seeking Alpha

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency ...

Aytu BioPharma, Inc. (AYTU) Interactive Stock Chart - Yahoo Finance

3y ago, source: Yahoo Finance

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript February 14, 2024 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25.

Panbela Therapeutics Inc (PBLA)

10mon ago, source: Investing

The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, ...

First Wave BioPharma, Inc.

2y ago, source: CNN

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...